Form 4/A for CRL Charles River Laboratories
Accepted 2024-05-29 00:00:00 ET · period of report 2024-03-08 · accession 0001127602-24-016791 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2024-05-29 | 2024-03-08 | CRL | Knell Michael Gunnar | CAO, CSVP | M - OptEx | $267.52 | +808 | 8,633 | +10% | +$216.2K |
| DA | 2024-05-29 | 2024-03-08 | CRL | Knell Michael Gunnar | CAO, CSVP | S - Sale+OE | $267.52 | -808 | 7,825 | -9% | -$216.2K |
| DA | 2024-05-29 | 2024-03-08 | CRL | Knell Michael Gunnar | CAO, CSVP | M - OptEx | $0.00 | -808 | 404 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | M | A | 808 | $267.52 | 8,633 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-08 | S | D | 808 | $267.52 | 7,825 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2024-03-08 | M | D | 808 | $0.00 | 404 | D | $179.66 · 2021-05-29 to 2030-05-29 | 808 Common Stock |